Reported by Seeking Alpha · seekingalpha.com · August 6, 2026
Exelixis (EXEL) Q2 2026 earnings call recap: lowered revenue guidance on slower NET ramp, cabo trends, zanzalintinib CRC filing, and catalysts—read now.
What to watch: EXEL (EXEL) cut guidance — a cut like this often precedes further estimate revisions across the sector.
Market reaction today: $EXEL +0.87%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.